Literature DB >> 16207150

Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip.

Chin-Hung Liu1, Konan Peck, Jin-Ding Huang, Min-Shung Lin, Chin-Hsiung Wang, Wen-Pin Hsu, Hong-Wen Wang, Hui-Ling Lee, Ming-Liang Lai.   

Abstract

Human cytochrome P450 (CYP)3A is a major P450 enzyme found in the liver and gastrointestinal tract. It plays an important role in the metabolism of a wide variety of drugs, some endogenous steroids and harmful environmental contaminants. It has been shown that CYP3A alleles encoding enzymes with little or no activity are largely created by single nucleotide polymorphisms (SNPs) in the sequences of these genes. The most prevalent of these SNPs are often of low allelic frequency, and many are specific to certain ethnic groups. Therefore, an accurate determination of their frequency in any given ethnic population requires investigations involving large sample sizes. A genotyping chip with enzyme-colorimetric detection was developed and used for simultaneous analysis of 22 known CYP3A SNPs in 451 Han Chinese subjects. Following multiplex polymerase chain reaction and allele-specific primer extension labeling, an enzymatic colorimetry detection system was employed to visualize genotype patterns on a nylon membrane. With this robust system, accurate discrimination ratios were obtained, and approximately 9,922 genotypes were determined. We found that the major CYP3A SNPs in the Chinese subjects were CYP3A4*4 (allele frequency 2.4%), CYP3A4*5 (0.7%), CYP3A4*18A (2.7%) and CYP3A5*3C (70.2%). Most of the major CYP3A4 SNPs found in other ethnicities were not found in this study. Using these SNPs, 11 haplotypes were identified. Comparison between present and previous studies shows that CYP3A4*4 and CYP3A4*5 alleles were Chinese-specific. The genotyping chip developed in this study is an efficient, economic and accurate system for screening multiple SNPs in a large population. Application of such technology is expected to be less labor intensive and easier to adapt to specific searches when compared with other methodologies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207150     DOI: 10.2217/14622416.6.7.731

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  5 in total

1.  Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors:  Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  CYP3A5*3 and MDR1 C3435T are influencing factors of inter-subject variability in rupatadine pharmacokinetics in healthy Chinese volunteers.

Authors:  Yuqing Xiong; Zhao Yuan; Jingzhi Yang; Chunhua Xia; Xinhua Li; Shibo Huang; Hong Zhang; Mingyi Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-11-27       Impact factor: 2.441

Review 3.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

4.  Functional characteristics of CYP3A4 allelic variants on the metabolism of loperamide in vitro.

Authors:  Qian-Meng Lin; Ying-Hui Li; Qian Liu; Ni-Hong Pang; Ren-Ai Xu; Jian-Ping Cai; Guo-Xin Hu
Journal:  Infect Drug Resist       Date:  2019-09-10       Impact factor: 4.003

5.  Assessment of Hepatic Cytochrome P450 3A Activity Using Metabolic Markers in Patients with Renal Impairment.

Authors:  Andrew HyoungJin Kim; Sumin Yoon; Yujin Lee; Jieon Lee; Eunjin Bae; Hajeong Lee; Dong Ki Kim; SeungHwan Lee; Kyung-Sang Yu; In-Jin Jang; Joo-Youn Cho
Journal:  J Korean Med Sci       Date:  2018-10-31       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.